Mehmet
Candas is a scientist, educator and occasional
multimedia artist at The University of Texas at Dallas. He
teaches at the School of Natural Sciences and Mathematics. His
courses include Biochemistry, Molecular Cell Biology, Biotechnology,
Proteomics, Cellular Microbiology, Modern Biology, and Human Body
Systems. Previously he served as Research Manager at the Center
for Biotechnology and Bioinformatics. At this position, he conducted
research on cell adhesion receptors and bacterial toxins. He also
helped start a company focusing on agricultural and environmental
biotechnology. As the scientific co-founder and internal
consultant to the company, he provided strategic and operational
leadership for the R&D projects. He implemented a technology
platform for genomic-based product development. The platform
integrated bioinformatics and proteomics applications with laboratory
robotics, enabling processing of multi-species genetic sequences to
select highly-specific DNA primers by discriminating protein conserved
domains in complex samples. The technology facilitated high-throughput
cloning and construction of gene libraries utilized to identify
expression-ready cDNA clones, which were used to screen drug and
insecticide targets in cell-based functional assays.
Prior
to UT-Dallas, Dr. Candas was at Cytoclonal
Pharmaceutics. His work concentrated on recombinant protein
expression vectors and live bacteria vaccine delivery
technologies, which aimed applications for
immune stimulation and treatment of infectious diseases and
cancer.
Before coming to the U.S., Dr. Candas was a faculty member in Ankara
University, School of Medicine (Türkiye) where he taught Medical
Biology and
Clinical Genetics. Prior that, he worked at Düzen
Laboratories; a medical technology and molecular diagnostics
services
company specializing in clinical biochemistry, microbiology and medical
imaging.
Dr.
Candas earned his PhD degree from Southern Methodist
University (Dallas, Texas), and MS and BS degrees from Middle East
Technical
University (Ankara, Türkiye) with specialties in molecular
genetics, biochemistry
and microbiology. In his doctoral dissertation, he studied
antioxidant
defenses and the aging process. He characterized the
glutathione/thioredoxin reductase gene in Drosophila
melanogaster. His
work set the stage for overexpression of the gene in transgenic
Drosophila and
facilitated understanding its role in survival extension under
oxidative
stress. His Master's thesis covered studies on RNA modifications
in
cancer. He studied differences in transfer RNA populations
between normal
tissues and tumors in human brain cancers. His postdoctoral work
involved
studies in bacterial metabolism and virulence regulation. He
investigated
propionate metabolism and biofilm production in Pseudomonas aeruginosa,
and
identified molecular targets suitable for development of new
anti-infectives. His current research interests focus on
intracellular
signaling pathways associated with cell adhesion receptors, and
bacteria and
insect systems as paradigms for microbe-host interactions. He
studies structural
and functional aspects of adhesion receptors and cell death signaling
cascades
with the goal of understanding regulatory pathways involved in
development, and
determining biochemical mechanisms of microbial toxins, drugs and
insecticide
action. His studies suggest broad implications for the
involvement of gut
epithelium in physiological responses and provide new insight into the
genetic
basis of cellular resistance to stress.
Dr.
Candas completed a wide spectrum of projects spanning
from research studies in aging, cancer and infectious diseases to
development
of biotechnology products involving drug discovery, DNA vaccines, crop
protection, bioremediation and soil improvement. His
accomplishments have
been described in several patents and journal articles, and he has been
a
featured speaker at scientific meetings and industry trade
conferences.
Dr. Candas lives in vibrant Dallas.
|